Impax, Endo Say FTC's Win Doesn't Help Opana Buyers
By Matthew Perlman · April 21, 2021, 6:30 PM EDT
Endo Pharmaceuticals Inc. and Impax Laboratories Inc. told an Illinois federal court that buyers who say they overpaid for Opana ER have to show more than the Federal Trade Commission did...
To view the full article, register now.